News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Alejandro Rodriguez

Articles by Alejandro Rodriguez

116 Impact of Neoadjuvant Chemotherapy (NACT) Response on Clinical Outcomes With Ribociclib (RIB) in HR+/HER2− EBC: A Subgroup Analysis From the Phase 3 NATALEE Trial

ByNicholas McAndrew,Stephen Chia,Fabio Puglisi,Yann Izarzugaza,Christian Schem, MD,Binghe Xu,Fanny Le Du,Priyanka Sharma, MD,Peter A. Fasching,Alejandro Rodriguez,Murat Akdere,Yogesh Chattar,Juan Pablo Zarate,Aditya Bardia, MD, MPH, FASCO

May 13th 2026

Latest Updated Articles

Trending on CancerNetwork

MYTHIC Trial Demonstrates Efficacy in Platinum-Resistant Ovarian Cancer

FDA Approves Sonrotoclax in Relapsed/Refractory Mantle Cell Lymphoma

FDA OKs Oral Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AML

Zoldonrasib Shows Promising Activity in KRAS G12D+ NSCLC

117 Risk of Recurrence (ROR) Among Patients With HR+/HER2− Early Breast Cancer (EBC) Involving 1-3 Axillary Lymph Nodes (N1): A Real-World Evaluation